CTMX – cytomx therapeutics, inc. (US:NASDAQ)
Stock Stats
News
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 [Yahoo! Finance]
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Barclays Raises its Price Target on CytomX Therapeutics, Inc. (CTMX) to $10 and Maintains an Overweight Rating [Yahoo! Finance]
CytomX Therapeutics (NASDAQ:CTMX) had its price target raised by analysts at Cantor Fitzgerald from $6.00 to $10.00. They now have an "overweight" rating on the stock.
CytomX Therapeutics to Present at Upcoming February Conferences [Yahoo! Finance]
Form SCHEDULE 13G CytomX Therapeutics, Filed by: Kynam Capital Management, LP
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: ORBIMED ADVISORS LLC
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: FMR LLC
Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Lester Rachael
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.